Heritage Cannabis Holdings Corp. (HERTF) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Heritage Cannabis Holdings Corp. (HERTF) trades at $0.0014 with AI Score 45/100 (Grade C). Heritage Cannabis Holdings Corp. Market cap: $3.47M, Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Jun 15, 2026Analyst Coverage for HERTF: HERTF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates HERTF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
HERTF: 2/3 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Heritage Cannabis Holdings Corp. (HERTF) Healthcare & Pipeline Overview
Heritage Cannabis Holdings Corp. is a Canada-based cannabinoid enterprise focused on extracting and developing diverse extract-based and derivative cannabis products for adult-use and medical markets across Canada and the United States. The company operates through multiple brands, including Purefarma, Pura Vida, Premium 5, RAD, feelgood., ArthroCBD, and CB4, offering a broad spectrum of cannabis solutions.
What Is the Investment Thesis for HERTF?
Heritage Cannabis Holdings Corp. operates within the evolving cannabinoid industry, leveraging a diversified product portfolio and a multi-brand strategy to target both adult-use recreational and medical markets across Canada and the United States. Key value drivers include its expertise in cannabinoid extraction and the development of a wide array of derivative products, which positions the company to capitalize on growing consumer acceptance and market expansion. Despite a current negative profit margin of -67.4%, the company maintains a gross margin of 28.0%, indicating some efficiency in its cost of goods sold. Growth catalysts are primarily linked to the ongoing liberalization of cannabis regulations in North America and the potential for new product introductions. However, as an OTC Other tier stock with a market capitalization of $3.47M, the company faces significant risks, including potentially limited liquidity, unknown disclosure status, and the necessity of securing further financing to support its operations and growth initiatives. Its Beta of 0.44 suggests lower volatility compared to the broader market, yet the inherent risks of an emerging, highly regulated industry remain pertinent for investor consideration.
Based on FMP financials and quantitative analysis
HERTF Key Highlights
Market Capitalization: The company currently holds a market capitalization of $3.47M, reflecting its status as a micro-cap entity.
- Profit Margin: Heritage Cannabis Holdings Corp. reported a profit margin of -67.4%, indicating significant unprofitability from its operations.
- Gross Margin: The company achieved a gross margin of 28.0%, demonstrating the profitability of its core product sales before operating expenses.
- Market Volatility (Beta): With a Beta of 0.44, the stock exhibits lower volatility relative to the overall market, suggesting a less sensitive response to market fluctuations.
- Employee Count: The company employs 89 individuals, indicating a relatively lean operational structure for its scope of business.
Who Are HERTF's Competitors?
HERTF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| INNPF INNOCAN PHARMA Corp | $1.60 | -8.05% | $7.20M | 61 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.3M | 63 |
| GBLP Global Pharmatech, Inc. | $0.08 | +0.00% | $33.3M | 62 |
| ETST Earth Science Tech, Inc. | $0.12 | +14.45% | $35.3M | 61 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.1M | 64 |
| MNNGF Baijin Life Science Holdings Limited | $0.08 | +0.00% | $74.6M | 63 |
| SHIEF Shield Therapeutics plc | $0.07 | +0.00% | $75.3M | 62 |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109M | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are HERTF's Key Strengths?
Diversified product portfolio and multi-brand strategy catering to various market segments.
- Expertise in cannabinoid extraction and derivative product development.
- Operational presence in both Canadian and United States markets.
- Wide range of product formats, including concentrates, edibles, and topical applications.
What Are HERTF's Weaknesses?
Significant negative profit margin of -67.4%, indicating persistent unprofitability.
- OTC Other tier status, which can imply limited liquidity and reporting requirements.
- Relatively small market capitalization of $3.47M.
- Reliance on securing further financing to support operational expansion and growth.
What Could Drive HERTF Stock Higher?
HERTF catalyst: Growing consumer acceptance of cannabis products in certain markets, which could drive increased demand for Heritage Cannabis's diverse offerings.
- Potential for new regulatory approvals or market liberalizations in key geographic areas, particularly in the United States, which could open new avenues for expansion and revenue generation.
- Introduction of new derivative products or expansion of existing brand lines to capture emerging consumer preferences and market trends in the cannabinoid sector.
- Efforts to secure further financing to support operational expansion, product development, and market penetration initiatives, which are crucial for sustained growth.
What Are the Key Risks for HERTF?
Financial-distress signal — its Altman Z-Score of -3.76 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-66.1%) — the business is not currently generating profit on shareholder capital.
- Higher risk profile due to its OTC Other tier status, which typically entails limited liquidity, wider bid-ask spreads, and potentially less stringent reporting requirements.
- Challenges in securing further financing, which could impede the company's ability to fund operational expansion, product innovation, and market development.
- Significant negative profit margin of -67.4%, indicating persistent unprofitability that could strain financial resources and impact long-term viability.
- Adverse regulatory changes or increased scrutiny within the cannabis industry across Canada and the United States, which could impact operations, market access, or product legality.
- Intense competition within the specialized and generic drug manufacturing sector, particularly in the rapidly evolving cannabinoid market, potentially pressuring pricing and market share.
What Are the Growth Opportunities for HERTF?
- Expanding Product Portfolio and Brand Diversification: Heritage Cannabis Holdings Corp. has a significant opportunity to deepen its market penetration by further expanding its diverse product portfolio and leveraging its established brands. By continuously innovating within its existing brand ecosystem—Purefarma, Pura Vida, Premium 5, RAD, feelgood., ArthroCBD, and CB4—the company can introduce novel cannabinoid formulations, new delivery methods, and specialized products. This ongoing diversification can enhance customer loyalty and reduce reliance on any single product line.
- Geographic Expansion within North America: The ongoing trend of cannabis legalization across various U.S. states presents a substantial growth opportunity for Heritage Cannabis. As more states regulate cannabis for medical or adult-use, the company can strategically enter these new markets, either through direct operations, licensing agreements, or strategic partnerships. Leveraging its existing operational experience in Canada and its presence in the U.S., Heritage can adapt its proven extraction and product development models to new regulatory environments. This expansion could unlock access to new consumer bases and significant revenue streams, contributing to long-term growth as the North American market continues to mature over the next 5-10 years.
- Research and Development in Cannabinoid Applications: Investing further in research and development (R&D) to explore novel therapeutic applications of cannabinoids represents a critical growth pathway. Beyond its current medical solutions, Heritage Cannabis could identify and develop products targeting specific medical conditions or wellness needs, potentially leading to proprietary formulations or intellectual property. This focus on scientific innovation could open doors to partnerships with pharmaceutical companies or healthcare providers, expanding its reach into more specialized and higher-value segments of the healthcare market. Such R&D initiatives, while long-term (5-10+ years), could establish Heritage as a leader in specific cannabinoid-based therapies, offering a strong competitive advantage.
- Strategic Partnerships and Mergers & Acquisitions: Heritage Cannabis can accelerate its growth and market reach through strategic partnerships, joint ventures, or targeted mergers and acquisitions (M&A). Collaborating with established distributors, cultivators, or technology providers could enhance its supply chain efficiency, expand its distribution networks, or integrate new technologies. Acquiring smaller, innovative cannabis companies could also provide access to new product lines, intellectual property, or market segments, consolidating its position in the competitive landscape. These strategic moves, potentially unfolding over the next 3-5 years, could significantly increase market share, operational scale, and overall profitability by leveraging synergies and reducing competitive pressures.
- Focus on High-Margin Derivative Products: A concerted effort to prioritize and expand the development and sale of high-margin derivative products, such as concentrates, edibles, and specialized oils, offers a direct path to improved financial performance. These products often command higher price points and offer better profit margins compared to traditional raw cannabis flower. By refining its extraction processes and innovating in product formulation, Heritage Cannabis can enhance the quality and appeal of its premium concentrates (Pura Vida, Premium 5, RAD) and specialized applications (CB4, ArthroCBD). This strategic focus, with a timeline of 1-3 years, can optimize the company's revenue mix, improve its overall profitability, and strengthen its brand reputation in the value-added segment of the cannabis market.
What Threats Does HERTF Face?
- Evolving and uncertain regulatory environment in the cannabis industry across North America.
- Intense competition from numerous established and emerging players in the cannabinoid market.
- Potential for limited access to capital and challenges in securing necessary financing.
- Reputational risks and public perception challenges associated with the cannabis sector.
- Limited disclosure and transparency due to its OTC Other listing status.
What Are HERTF's Competitive Advantages?
- Diversified brand portfolio catering to multiple market segments (recreational, medical, wellness) with distinct product offerings.
- Established expertise in cannabinoid extraction and the development of a wide range of derivative products.
- Operational presence and capabilities in both the Canadian and United States cannabis markets.
- Comprehensive product formats, including concentrates, edibles, oils, capsules, sublingual films, and topical applications, addressing varied consumer preferences.
What Does HERTF Do?
Heritage Cannabis Holdings Corp. is a cannabinoid-focused enterprise with operations spanning across Canada and the United States through its various subsidiaries. The company's foundational business model centers on the extraction of cannabinoids, which then serves as the basis for the development of a diverse portfolio of extract-based and derivative products. These offerings are strategically designed to cater to two primary market segments: the adult-use recreational market and the provision of cannabis-based medical solutions. The company was initially incorporated in 2007 under the name Umbral Energy Corp. and subsequently adopted its current identity, Heritage Cannabis Holdings Corp., in January 2018, reflecting its evolved strategic focus within the cannabis industry. Headquartered in Toronto, Canada, Heritage Cannabis has established a significant presence through a multi-brand strategy, each targeting specific consumer needs and product categories. Its brand lineup includes Purefarma, which delivers medicinal-grade cannabis formulations applicable across pharmaceutical, recreational, and cosmeceutical sectors. Pura Vida specializes in concentrates derived from various strains, including CBD, indica, sativa, and hybrid varieties. Premium 5 is dedicated to tetrahydrocannabinol (THC) concentrates, while the RAD brand also features a range of concentrates. Beyond recreational and medicinal concentrates, the company extends its reach into wellness and skincare with the feelgood. brand, and offers specialized hemp-based formulations through ArthroCBD. Furthermore, its CB4 brand encompasses a variety of orally administered products such as capsules and sublingual filmstrips, alongside topical applications like gels and creams, demonstrating a comprehensive approach to product development and market penetration.
What Products and Services Does HERTF Offer?
- Extract cannabinoids from cannabis plants for various product applications.
- Develop a diverse portfolio of extract-based cannabis products.
- Produce derivative cannabis products, including concentrates, edibles, and oils.
- Offer products for the adult-use recreational cannabis market.
- Provide cannabis-based medical solutions for patients.
- Market products under distinct brands such as Purefarma, Pura Vida, Premium 5, RAD, feelgood., ArthroCBD, and CB4.
- Specialize in various product formats, including concentrates, orally administered capsules, sublingual filmstrips, and topical applications.
- Operate across Canada and the United States through its subsidiaries.
How Does HERTF Make Money?
- Generating revenue through the sale of a diverse portfolio of extract-based cannabis products to both recreational and medical consumers.
- Monetizing derivative products, including concentrates, edibles, and oils, under various brand names like Purefarma, Pura Vida, Premium 5, and RAD.
- Supplying specialized cannabis formulations for the pharmaceutical, recreational, and cosmeceutical sectors via brands such as Purefarma.
- Selling wellness and skincare products containing cannabinoids through brands like feelgood. and specialized hemp-based formulations via ArthroCBD.
What Industry Does HERTF Operate In?
Heritage Cannabis Holdings Corp. operates within the dynamic and rapidly evolving Drug Manufacturers - Specialty & Generic industry, specifically focusing on the cannabinoid sector. The company's positioning is centered on the extraction of cannabinoids and the subsequent development of a diverse range of extract-based and derivative products for both adult-use recreational and medical applications. This places Heritage Cannabis within a competitive landscape characterized by numerous players vying for market share in a sector driven by evolving regulatory frameworks and increasing consumer acceptance. The broader cannabis market continues to experience significant growth, fueled by ongoing legalization efforts and expanding product innovation. Heritage Cannabis aims to differentiate itself through its multi-brand strategy and comprehensive product offerings, from medicinal formulations to recreational concentrates and wellness products, seeking to capture various segments of this expanding market.
Who Are HERTF's Key Customers?
- Adult-use recreational cannabis consumers seeking various product forms, including concentrates and edibles.
- Patients requiring cannabis-based medical solutions, including medicinal-grade formulations and specialized therapeutic applications.
- Consumers interested in general wellness and skincare products that incorporate cannabinoids.
- Pharmaceutical and cosmeceutical industries for specialized cannabinoid formulations and ingredients.
Financial Health
Heritage Cannabis Holdings Corp.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -3.76 places it in the distress zone, a signal of elevated financial risk.
HERTF Valuation & Market Position
With a $3.47M market cap, Heritage Cannabis Holdings Corp. sits in the micro-cap segment of the market. Relative to its peer group, HERTF's quantitative score of 45/100 is below the peer average of 62/100.
Key Financial Metrics
Return on equity for Heritage Cannabis Holdings Corp. stands at -66.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -36.0%, showing how much profit it generates from its asset base. Its free cash flow yield is -1.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.28 indicates the company holds enough short-term assets to cover its near-term obligations.
Company Profile
Heritage Cannabis Holdings Corp. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Toronto, CA. The company is led by CEO David Werner-Paul Schwede. HERTF has traded publicly since 2014.
HERTF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Diversified product portfolio and multi-brand strategy catering to various market segments.
- Expertise in cannabinoid extraction and derivative product development.
- Operational presence in both Canadian and United States markets.
- Wide range of product formats, including concentrates, edibles, and topical applications.
Bear Case
- Significant negative profit margin of -67.4%, indicating persistent unprofitability.
- OTC Other tier status, which can imply limited liquidity and reporting requirements.
- Relatively small market capitalization of $3.47M.
- Reliance on securing further financing to support operational expansion and growth.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
HERTF Latest News
No recent news available for HERTF.
HERTF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for HERTF.
Price Targets
Wall Street price target analysis for HERTF.
HERTF MoonshotScore
What does this score mean?
The MoonshotScore rates HERTF 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: David Werner-Paul Schwede
Chief Executive Officer
Unknown
Track Record: Unknown
HERTF OTC Market Information
Heritage Cannabis Holdings Corp. trades on the OTC Other tier, which is the lowest of the three tiers for over-the-counter securities, below OTCQX and OTCQB. Unlike stocks listed on major exchanges like the NYSE or NASDAQ, OTC Other companies have minimal financial reporting requirements, often providing little to no public information. This tier is typically for companies that do not meet the standards for higher tiers or major exchanges, resulting in less transparency and higher risk for investors. It contrasts sharply with the stringent listing and reporting rules of national exchanges, which mandate regular, audited financial statements and adherence to corporate governance standards.
- OTC Tier: OTC Other
- Limited Liquidity: Trading on the OTC Other tier often results in low trading volumes and wide bid-ask spreads, making it difficult to buy or sell shares efficiently.
- Unknown Disclosure Status: The company's 'Unknown' disclosure status implies a lack of readily available, regular financial reporting, hindering informed investment decisions.
- Financing Challenges: As highlighted by AI insights, the company's ability to secure further financing is a critical risk, impacting growth and operational stability.
- Regulatory Uncertainty: The cannabis industry is subject to dynamic and often unpredictable regulatory changes across different jurisdictions, posing ongoing compliance and market risks.
- Price Volatility: Due to lower liquidity and less public information, OTC Other stocks can experience higher price volatility, increasing investment risk.
- Verify any available financial reports, even if unaudited, directly from the company or third-party sources.
- Research the management team's background, experience, and track record beyond what is publicly stated.
- Assess the company's business model, product differentiation, and competitive landscape within the cannabis industry.
- Investigate any news, press releases, or corporate actions that may provide insights into its operational status and future plans.
- Understand the specific regulatory environment in Canada and the U.S. states where Heritage Cannabis operates.
- Evaluate the company's capital structure and any recent financing activities to gauge its financial health and funding needs.
- Consider the potential for market manipulation and the general risks associated with thinly traded securities.
- Established in 2007 (as Umbral Energy Corp.), indicating a long operational history, albeit with a name change.
- Operates across Canada and the United States, suggesting a broader market reach than many micro-cap OTC companies.
- Possesses a diverse portfolio of distinct brands and products, demonstrating active business operations and market engagement.
- Focuses on a specific industry (cannabinoid extraction and product development) with a clear business description.
Heritage Cannabis Holdings Corp. Healthcare Stock: Key Questions Answered
What does the AI Score mean for HERTF?
HERTF holds an AI Score of 45/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Heritage Cannabis Holdings Corp. is a cannabinoid-focused enterprise operating in Canada and the United States, specializing in the extraction and development of diverse extract-based …
What does Heritage Cannabis Holdings Corp. do?
Heritage Cannabis Holdings Corp. is a cannabinoid-focused enterprise engaged in the extraction of cannabinoids and the development of a diverse range of extract-based and derivative products. The company operates across Canada and the United States, serving both the adult-use recreational market and providing cannabis-based medical solutions.
What revenue streams does Heritage Cannabis Holdings Corp. have in healthcare?
Heritage Cannabis Holdings Corp. generates revenue in the healthcare sector primarily through its focus on cannabis-based medical solutions and specialized formulations. The Purefarma brand, for instance, delivers medicinal-grade cannabis formulations that cater to pharmaceutical, recreational, and cosmeceutical sectors, indicating a direct link to healthcare applications.
What are the main risks for HERTF?
The main risks for Heritage Cannabis Holdings Corp. (HERTF) are multifaceted, stemming from its operational context and market position. As an OTC Other tier stock, HERTF faces inherent risks such as potentially limited liquidity and unknown disclosure status, which can hinder investor transparency and trading efficiency.
How does Heritage Cannabis Holdings Corp.'s OTC listing impact investors?
Heritage Cannabis Holdings Corp.'s listing on the OTC Other tier has several significant implications for investors. Firstly, it typically means lower trading volumes and wider bid-ask spreads compared to stocks on major exchanges, potentially leading to reduced liquidity and difficulty in executing trades at desired prices.
What are the key factors to evaluate for HERTF?
Heritage Cannabis Holdings Corp. (HERTF) holds an AI score of 45/100 (low). operates within the evolving cannabinoid industry, leveraging a diversified product portfolio and a multi-brand strategy to target both adult-use recreational and medical markets across Canada and the United States. Not financial advice.
How frequently does HERTF data refresh on this page?
HERTF's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven HERTF's recent stock price performance?
Heritage Cannabis Holdings Corp. (HERTF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified product portfolio and multi-brand strategy catering to various market segments. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider HERTF overvalued or undervalued right now?
Heritage Cannabis Holdings Corp. (HERTF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information regarding CEO background, track record, and tenure is not available in the provided source data.
- Competitor information (FMP PEER TICKERS) was not provided in the source data.